Hookipa Pharma Inc (NASDAQ:HOOK) price on Friday, May 02, rose 1.52% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.34.
A look at the stock’s price movement, the close in the last trading session was $1.32, moving within a range at $1.25 and $1.5. The beta value (5-Year monthly) was 0.774. Turning to its 52-week performance, $105.00 and $0.72 were the 52-week high and 52-week low respectively. Overall, HOOK moved 46.18% over the past month.
Hookipa Pharma Inc’s market cap currently stands at around $16.16 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-27.
Analysts have a consensus estimate of 3.38M for the company’s revenue for the quarter, with a low and high estimate of 3.38M and 3.38M respectively. The average forecast suggests down to a -90.78% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 13.5M, representing a -69.28% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that HOOK is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend HOOK as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
HOOK’s current price about 57.65% and 21.00% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 72.71, while 7-day volatility ratio is 18.50% and 12.46% in the 30-day chart. Further, Hookipa Pharma Inc (HOOK) has a beta value of 0.67, and an average true range (ATR) of 0.12. Analysts have given the company’s stock an average 52-week price target of $3, forecast between a low of $3 and high of $3. Looking at the price targets, the low is -123.88% off current price level while to achieve the yearly target high, price needs to move -123.88%. Nonetheless, investors will most likely welcome a -123.88% jump to $3 which is the analysts’ median price.
If we refocus on Hookipa Pharma Inc (NASDAQ:HOOK), historical trading data shows that trading volumes averaged 0.21 over the past 10 days and 67.50K over the past 3 months. The company’s latest data on shares outstanding shows there are 9.66 million shares.
The 42.92% of Hookipa Pharma Inc’s shares are in the hands of company insiders while institutional holders own 24.08% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 12919.0 on 2025-04-15, giving us a short ratio of 0.32. The data shows that as of 2025-04-15 short interest in Hookipa Pharma Inc (HOOK) stood at 17.0 of shares outstanding, with shares short falling to 70638.0 registered in 2025-03-14. Current price change has pushed the stock -33.33% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the HOOK stock continues to rise going into the next quarter.
